Cargando…
In Vitro and In Vivo Investigation of the Efficacy of Arylimidamide DB1831 and Its Mesylated Salt Form - DB1965 - against Trypanosoma cruzi Infection
Chagas disease is caused by infection with the intracellular protozoan parasite Trypanosoma cruzi. At present, nifurtimox and benznidazole, both compounds developed empirically over four decades ago, represent the chemotherapeutic arsenal for treating this highly neglected disease. However, both dru...
Autores principales: | da Silva, Cristiane França, Batista, Denise da Gama Jaen, Oliveira, Gabriel Melo, de Souza, Elen Mello, Hammer, Erica Ripoll, da Silva, Patricia Bernardino, Daliry, Anissa, Araujo, Julianna Siciliano, Britto, Constança, Rodrigues, Ana Carolina Mondaine, Liu, Zongying, Farahat, Abdelbasset A., Kumar, Arvind, Boykin, David W., de Nazaré Correia Soeiro, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264605/ https://www.ncbi.nlm.nih.gov/pubmed/22291940 http://dx.doi.org/10.1371/journal.pone.0030356 |
Ejemplares similares
-
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
por: da Silva, Cristiane França, et al.
Publicado: (2017) -
Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease
por: Timm, Bruno Lisboa, et al.
Publicado: (2023) -
Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents
por: Zhu, Xiaohua, et al.
Publicado: (2016) -
Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011) -
Imatinib Mesylate Reduces Endoplasmic Reticulum Stress and Induces Remission of Diabetes in db/db Mice
por: Han, Myoung Sook, et al.
Publicado: (2009)